Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction: A Randomized Controlled Trial

NCT04347122 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT04347122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04347122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction: A Randomized Controlled Trial
Lead sponsor
University of Kansas Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
January 28, 2020
Completion date
August 18, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal cancer, sarcoma,soft tissue